202 related articles for article (PubMed ID: 21304000)
1. Markers of pancreatic cancer: working toward early detection.
Goggins M
Clin Cancer Res; 2011 Feb; 17(4):635-7. PubMed ID: 21304000
[TBL] [Abstract][Full Text] [Related]
2. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
3. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
Kriz D; Ansari D; Andersson R
Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
[TBL] [Abstract][Full Text] [Related]
4. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
Babic A; Wolpin BM
Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
[No Abstract] [Full Text] [Related]
5. Protein-metabolite panel for early-stage pancreatic cancer.
Burki TK
Lancet Oncol; 2018 Oct; 19(10):e512. PubMed ID: 30146244
[No Abstract] [Full Text] [Related]
6. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
Caputo D; Caracciolo G
Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
[TBL] [Abstract][Full Text] [Related]
7. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
8. Urine test can detect early stage pancreatic cancer.
Bagcchi S
Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
[No Abstract] [Full Text] [Related]
9. Pancreatic cancer: current understanding of molecular and genetic aetiologies.
Gall TM; Wasan H; Jiao LR
Postgrad Med J; 2015 Oct; 91(1080):594-600. PubMed ID: 26124188
[TBL] [Abstract][Full Text] [Related]
10. Early detection and imaging strategies to reveal and target developing pancreatic cancer.
Crawford HC; Wallace MB; Storz P
Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932
[No Abstract] [Full Text] [Related]
11. Screening for Pancreatic Cancer.
Wada K; Takaori K; Traverso LW
Surg Clin North Am; 2015 Oct; 95(5):1041-52. PubMed ID: 26315522
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers in pancreatic ductal adenocarcinomas.
Hezel AF; Bardeesy N
Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
[No Abstract] [Full Text] [Related]
13. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
14. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
Chari ST; Sharma A; Maitra A
Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
[No Abstract] [Full Text] [Related]
15. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
16. Familial Pancreatic Cancer.
Benzel J; Fendrich V
Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
[TBL] [Abstract][Full Text] [Related]
17. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
19. "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer.
Comandatore A; Balsano R; Immordino B; Arguedas D; Capula M; Baglio SR; Garajovà I; Malapelle U; Morelli L; Giovannetti E
Crit Rev Oncol Hematol; 2022 May; 173():103659. PubMed ID: 35398264
[TBL] [Abstract][Full Text] [Related]
20. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
